1. Home
  2. SANA vs KBDC Comparison

SANA vs KBDC Comparison

Compare SANA & KBDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sana Biotechnology Inc.

SANA

Sana Biotechnology Inc.

N/A

Current Price

$2.01

Market Cap

688.5M

Sector

Health Care

ML Signal

N/A

Logo Kayne Anderson BDC Inc.

KBDC

Kayne Anderson BDC Inc.

N/A

Current Price

$12.83

Market Cap

822.8M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
SANA
KBDC
Founded
2018
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
688.5M
822.8M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
SANA
KBDC
Price
$2.01
$12.83
Analyst Decision
Strong Buy
Buy
Analyst Count
9
5
Target Price
$8.43
★ $14.00
AVG Volume (30 Days)
★ 2.6M
417.6K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
★ 12.43%
EPS Growth
★ 17.24
N/A
EPS
N/A
★ 1.30
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$9.88
Revenue Growth
N/A
N/A
52 Week Low
$2.00
$12.14
52 Week High
$5.49
$15.87

Technical Indicators

Market Signals
Indicator
SANA
KBDC
Relative Strength Index (RSI) 32.21 50.55
Support Level N/A $12.25
Resistance Level $3.41 $13.55
Average True Range (ATR) 0.19 0.32
MACD -0.02 0.02
Stochastic Oscillator 15.96 50.93

Price Performance

Historical Comparison
SANA
KBDC

About SANA Sana Biotechnology Inc.

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.

About KBDC Kayne Anderson BDC Inc.

Kayne Anderson BDC Inc is an externally managed, closed-end, non-diversified management investment company that has elected to be regulated as a business development company, investing mainly in first-lien senior secured loans, with a secondary focus on unitranche and split-lien loans to middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation mainly through debt investments in middle-market companies.

Share on Social Networks: